OP0031 Risk Factors for Malignancies Synchronous To The Onset of Systemic Sclerosis in Patients Positive for Anti- RNA Polymerase III Antibodies: A Eustar Multicentre Study
Maria Grazia Lazzaroni(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Paolo Airó(University of Lisbon), Alexandra Balbir‐Gurman(Technion – Israel Institute of Technology), É. Hachulla(Centre Hospitalier Universitaire de Lille), Vanessa Smith(Ghent University Hospital), Rucsandra Dobrota(University of Zurich), Roger Hesselstrand(Lund University), Cecília Varjú(Université Paris Cité), Paola Caramaschi(University of Verona), Yannick Allanore(Inserm), Ilaria Cavazzana(Université Paris Cité), Valeria Riccieri(Sapienza University of Rome), Oliver Distler(University Hospital of Zurich), Katarzyna Romanowska‐Próchnicka(Medical University of Lodz), E. Colombo(University of Sassari), Emmanuel Chatelus(Laboratoire National de Référence), László Czirják(University of Pecs), Gabriella Nagy(Université Paris Cité), Ana Cristina Oliveira Araújo(Hospital Curry Cabral), J. L. Corona Hernandez(University Hospital Zurich)
Cited by 0
Related Papers
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
|New England Journal of Medicine|2009|857
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456